Estradiol valerate 2mg tablets

Kraj: Wielka Brytania

Język: angielski

Źródło: MHRA (Medicines & Healthcare Products Regulatory Agency)

Kup teraz

Ulotka dla pacjenta Ulotka dla pacjenta (PIL)
15-11-2019

Składnik aktywny:

Estradiol valerate

Dostępny od:

Viatris UK Healthcare Ltd

Kod ATC:

G03CA03

INN (International Nazwa):

Estradiol valerate

Dawkowanie:

2mg

Forma farmaceutyczna:

Oral tablet

Droga podania:

Oral

Klasa:

No Controlled Drug Status

Typ recepty:

Valid as a prescribable product

Podsumowanie produktu:

BNF: 06040101

Ulotka dla pacjenta

                                IF YOU FORGET TO TAKE PROGYNOVA
If you forget to take a tablet at your usual time and you are less
than 12 hours late, take it as soon as possible. Take the next tablet
at the usual time.
If you are more than 12 hours late, leave the forgotten tablet in the
pack. Continue to take the rest of the tablets at the usual time every
day. You may experience breakthrough bleeding.
IF YOU STOP TAKING PROGYNOVA
You may begin to feel the usual symptoms of menopause again,
which may include hot flushes, trouble sleeping, nervousness,
dizziness or vaginal dryness. Consult your doctor or pharmacist if
you want to stop taking Progynova tablets.
IF YOU NEED TO HAVE SURGERY
If you are going to have surgery, tell the surgeon that you are taking
Progynova. You may need to stop taking Progynova about 4 to 6
weeks before the operation to reduce the risk of a blood clot (see
section 2, “Blood clots in a vein (thrombosis)”). Ask your doctor
when you can start taking Progynova again.
If you have any further questions on the use of this medicine, ask
your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side effects, although
not everybody gets them.
The following diseases are reported more often in women using
HRT compared to women not using HRT:
SERIOUS SIDE EFFECTS

breast cancer

abnormal growth or cancer of the lining of the womb
(endometrial hyperplasia or cancer)

ovarian cancer

blood clots in the veins of the legs or lungs (venous
thromboembolism)

heart disease

stroke

probable memory loss if HRT is started over the age of 65
For more information about these side effects see section 2.
OTHER SIDE EFFECTS that have been linked to the use of Progynova
and other oral hormone replacement therapies:

During the first few months of treatment you may experience
some vaginal bleeding at unexpected times (breakthrough
bleeding and spotting). These symptoms normally lessen with
continued treatment. If they don’t, contact your doctor (see
section 2 ‘HRT and cancer/
                                
                                Przeczytaj cały dokument
                                
                            

Wyszukaj powiadomienia związane z tym produktem